2010 ADVANCED TECHNOLOGIES FOR ENHANCING QUALITY OF LIFE (AT-EQUAL)

Frank Barry; Mary Murphy

doi:10.1109/ATEQUAL.2010.10

2010 ADVANCED TECHNOLOGIES FOR ENHANCING QUALITY OF LIFE (AT-EQUAL)

Frank Barry
, Mary Murphy

Medicine

Research output: Chapter in Book or Conference Publication/Proceeding › Conference Publication › peer-review

Abstract

Regenerating articular cartilage is a challenge for orthopedic surgery. Advanced therapeutical medicinal products (ATMP, including gene therapy, cell therapy, tissue engineering products) are offering promising solutions to structurally and functionally replace missing or degenerated musculoskeletal tissues. The paper reviews current cell based clinical available procedures as well as potential cell sources for cartilage regeneration. The compulsory steps in developing and implementing advanced medicine products, their particularities related to technological requirements, conceptual specificity, are stressed out. An important guideline for conceiving and productization of regenerative medicine therapeutical solution are European Union regulatory agreements for ATMP development and marketing authorization

Original language	English (Ireland)
Title of host publication	Cell sources for cartilage regeneration - from basic science to clinical reality
Number of pages	7
DOIs	https://doi.org/10.1109/ATEQUAL.2010.10
Publication status	Published - 1 Oct 2010

Authors (Note for portal: view the doc link for the full list of authors)

Authors
Simion, L,Botez, P,Murphy, M,Eloae, FZ,Barry, F,

Access to Document

10.1109/ATEQUAL.2010.10

Cite this

@inproceedings{818f7ad4e1014975976a8b828037b4eb,

title = "2010 ADVANCED TECHNOLOGIES FOR ENHANCING QUALITY OF LIFE (AT-EQUAL)",

abstract = "Regenerating articular cartilage is a challenge for orthopedic surgery. Advanced therapeutical medicinal products (ATMP, including gene therapy, cell therapy, tissue engineering products) are offering promising solutions to structurally and functionally replace missing or degenerated musculoskeletal tissues. The paper reviews current cell based clinical available procedures as well as potential cell sources for cartilage regeneration. The compulsory steps in developing and implementing advanced medicine products, their particularities related to technological requirements, conceptual specificity, are stressed out. An important guideline for conceiving and productization of regenerative medicine therapeutical solution are European Union regulatory agreements for ATMP development and marketing authorization",

author = "Frank Barry and Mary Murphy",

year = "2010",

month = oct,

day = "1",

doi = "10.1109/ATEQUAL.2010.10",

language = "English (Ireland)",

booktitle = "Cell sources for cartilage regeneration - from basic science to clinical reality",

}

TY - GEN

T1 - 2010 ADVANCED TECHNOLOGIES FOR ENHANCING QUALITY OF LIFE (AT-EQUAL)

AU - Barry, Frank

AU - Murphy, Mary

PY - 2010/10/1

Y1 - 2010/10/1

N2 - Regenerating articular cartilage is a challenge for orthopedic surgery. Advanced therapeutical medicinal products (ATMP, including gene therapy, cell therapy, tissue engineering products) are offering promising solutions to structurally and functionally replace missing or degenerated musculoskeletal tissues. The paper reviews current cell based clinical available procedures as well as potential cell sources for cartilage regeneration. The compulsory steps in developing and implementing advanced medicine products, their particularities related to technological requirements, conceptual specificity, are stressed out. An important guideline for conceiving and productization of regenerative medicine therapeutical solution are European Union regulatory agreements for ATMP development and marketing authorization

AB - Regenerating articular cartilage is a challenge for orthopedic surgery. Advanced therapeutical medicinal products (ATMP, including gene therapy, cell therapy, tissue engineering products) are offering promising solutions to structurally and functionally replace missing or degenerated musculoskeletal tissues. The paper reviews current cell based clinical available procedures as well as potential cell sources for cartilage regeneration. The compulsory steps in developing and implementing advanced medicine products, their particularities related to technological requirements, conceptual specificity, are stressed out. An important guideline for conceiving and productization of regenerative medicine therapeutical solution are European Union regulatory agreements for ATMP development and marketing authorization

U2 - 10.1109/ATEQUAL.2010.10

DO - 10.1109/ATEQUAL.2010.10

M3 - Conference Publication

BT - Cell sources for cartilage regeneration - from basic science to clinical reality

ER -

2010 ADVANCED TECHNOLOGIES FOR ENHANCING QUALITY OF LIFE (AT-EQUAL)

Abstract

Authors (Note for portal: view the doc link for the full list of authors)

Access to Document

Fingerprint

Cite this